Adam Ang
Also, Olympus has come up with the third-generation Visera Elite surgical visualisation platform for endoscopic procedures.
The Indian derma startup is also working to optimise its platform.
The new funds will go toward further scaling its platform in the United States.
It can also predict falls by using AI and a deep sensing camera that observes a wearer's movement.
It is currently conducting clinical studies and expanding its teams in Australia and the US.
The solution screens for plus disease, which is associated with severe ROP.
Individuals are also less likely to trust AI-suggested interventions than those recommended by humans.
The company will maintain its patent right for the technology.
Docquity will use its fresh funds to further expand into East Asia and the Middle East.
Also, Lunit has received Taiwan's approval for its AI mammography solution.